Pharmacokinetic Study of Terpinolene in Healthy Subjects (PKT Study)
1 other identifier
interventional
11
1 country
1
Brief Summary
The study aims to check if our prediction about the uptake, distribution, and elimination of terpinolene (a food additive commonly found in e.g. fruits and herbs) from the human body is accurate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 4, 2024
CompletedFirst Submitted
Initial submission to the registry
November 8, 2024
CompletedFirst Posted
Study publicly available on registry
November 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 3, 2024
CompletedDecember 4, 2024
December 1, 2024
29 days
November 8, 2024
December 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Plasma terpinolene concentration
Blood samples will be collected at 9 timepoints
24 hours
Study Arms (1)
Single arm
EXPERIMENTALn=15, single oral dose of 200mg of food-grade terpinolene in 5ml of olive oil
Interventions
Single oral dose of 200mg food-grade terpinolene in 5ml of olive oil
Eligibility Criteria
You may qualify if:
- Aged 21-50
- Chinese, Malay and Indian ethnicities
- Male or female
- Adequate fluency in the English language to understand the informed consent process, study instructions and study assessments
- Sufficient vision and hearing to complete the study procedures
- Willing and able to participate and to give written informed consent
You may not qualify if:
- Past (\<3 months prior to the study) or current major metabolic, endocrine, gastrointestinal or cardiovascular disease
- Individuals diagnosed with non-alcoholic fatty liver disease
- Major surgery in the past 2 months
- On chronic medication
- Allergy to olive oil
- Vegetarian/vegan
- Smoking
- Pregnant or lactating
- Alcohol intake \>1 units per day
- Body Mass Index \<18.5 kg/m2 or ≥27 kg/m2
- Body weight \<54 kg
- Member of the study team or their immediate family members
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Human Development Research Centre, IHDP, A*STAR
Singapore, 117597, Singapore
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Chan, PhD
Singapore Institute of Food and Biotechnology Innovation (SIFBI), A*STAR
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Scientist I
Study Record Dates
First Submitted
November 8, 2024
First Posted
November 15, 2024
Study Start
November 4, 2024
Primary Completion
December 3, 2024
Study Completion
December 3, 2024
Last Updated
December 4, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share